Interestingly, in T2D iHeps, insulin-mediated suppression of PCK1 was lost, while both basal and insulin-stimulated expression of FASN was increased almost 2-fold compared with the controls (Figure 1D). The gene discussed is FASN; the disease is type 2 diabetes mellitus.